🚀 The Future of Aging: Can We Reverse Time? episode artwork

EPISODE · Mar 13, 2025 · 37 MIN

🚀 The Future of Aging: Can We Reverse Time?

from Peggy Van de Plassche · host Peggy

My scale says I’m 12 years old. Science—and my 47-year-old body—might disagree. 😂But what if aging wasn’t inevitable? What if we could slow it down—or even reverse it?That’s exactly what I explored with Marco Quarta, longevity scientist & co-founder of Rubedo Life Science. His team is tackling one of aging’s biggest culprits: senescent cells (aka “zombie cells”)—which refuse to die and accelerate disease.💡 What’s coming next? 🔬 Targeted longevity treatments—Eliminating zombie cells to reduce inflammation & extend healthspan 🧬 Aging biomarkers—Tests that predict diseases before symptoms appear 🏛️ Regulatory change—Aging isn’t yet classified as a disease, slowing innovation. That could soon shift. 🌍 Big picture—This isn’t just about looking younger. It’s about preventing our healthcare system from collapsing under an aging population.The bottom line? Aging doesn’t have to mean decline. The science is moving fast—are we ready to embrace it?👉 Dive into the science & listen to my convo with Marco here. [Insert link]#Longevity #Biotech #FutureOfAging #Healthspan #Innovation #RegenerativeMedicinePeggy Van de Plassche is a value creation strategist and senior advisor with over 20 years of experience in private equity, financial services, healthcare, and technology. She works with investment firms, boards, and C-suite leaders to accelerate portfolio company performance, drive operational transformation, and unlock long-term value. Peggy specializes in the execution of complex value creation plans—spanning capital allocation, digital enablement, transaction advisory, and leadership alignment. Her work consistently bridges strategy and implementation, helping investors and operators maximize EBITDA and enterprise value. A founding board member of Invest in Canada, she also brings deep expertise in public-private partnerships and institutional capital deployment—critical levers for competitive advantage in today’s global landscape. Her clients have included BMO, CI Financial, HOOPP, OMERS, GreenShield Canada, Nicola Wealth, and Power Financial. Learn more at peggyvandeplassche.com.#privateequity #privatemarkets #alternativeinvestments #investing #investments #invest #venturecapital #investor #entrepreneur #digitaltransformation #ai #exit #tech #technology #finance #financialservices #healthcare

Episode metadata supplied by the publisher feed · Published Mar 13, 2025

Embed this episode

My scale says I’m 12 years old. Science—and my 47-year-old body—might disagree. 😂 But what if aging wasn’t inevitable? What if we could slow it down—or even reverse it? That’s exactly what I explored with Marco Quarta, longevity scientist & co-founder of Rubedo Life Science. His team is tackling one of aging’s biggest culprits: senescent cells (aka “zombie cells”)—which refuse to die and accelerate disease. 💡 What’s coming next? 🔬 Targeted longevity treatments—Eliminating zombie cells to...

Distinct summary based on available episode metadata or transcript content.

Ready to play

🚀 The Future of Aging: Can We Reverse Time?

0:00 37:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Peggy Van de Plassche?

This episode is 37 minutes long.

When was this Peggy Van de Plassche episode published?

This episode was published on March 13, 2025.

Can I download this Peggy Van de Plassche episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!